Just one year has passed since Merck’s Vioxx fiasco and major U.S. drug manufacturers are already facing a downward shift in sales as they attempt to work around an increasingly untrusting public.
Today's NY Times examines the big business of big drugs revealing an industry that while far from suffering, is unquestionably feeling the effects of shifting public opinion. Americans are becoming less responsive to drug manufacturer's marketing and promotion, the FDA is slow to approve many new medicines, and doctors are prescribing fewer controversial drugs like antidepressants and hormone replacement therapies.
Interests: Anything with an ING:
dancing, biking, listening, talking, writing, reading,
watching, eating, drinking, running, thinking, working, dreaming,
surrendering, laughing, smiling, acting, traveling, singing, surfing,
driving, shopping, thanking, observing, welcoming, connecting,
loving, learning, sharing, practicing, asking.
Inspiration: Books: Letters to a Young Poet, Rainer Maria Rilke/
Music: Linkin Park and The Cure/
People: My mother and all of those that have come before me that have fought their
own battles and didn't give up/
Places: Carl Schurz Park, New York, NY/
Movies: In Search of a Midnight Kiss, Stealing Beauty, Beautiful Girls, When A Man Loves a Woman, In America, Magdelene Sisters, The Notebook, Run Fat Boy Run/
Things: Causes worth fighting for: Lupus and other auto-immune disorders, Organ Donation and impoverished and at-risk youth.